Energy Transfer Therapy in Treatment of Medial Gastrocnemius

Effects of Capacitive and Resistive Energy Transfer Therapy in Pre and Post-treatment Medial Gastrocnemius in National Level Basketball Players

This study develops the effects of Capacitive and Resistive Energy Transfer Therapy (TECAR) on medial gastrocnemius using thermographic cameras, algometry and lunge tests, in a pre-post study with basketball players using a control group to which placebo is applied. (simulated technique) and an intervention group to which the technique is performed. The main objective of the study is to establish whether the TECAR produces physiological and mechanical changes in the subjects that improve muscle recovery.

Study Overview

• Status: Completed
• Conditions: Sports Physical Therapy; Thermography; Strain of Gastrocnemius Muscle (Diagnosis); Diathermy Plate Burn
• Intervention / Treatment: Other: Placebo; Procedure: TECAR Therapy

• Study Type: Interventional
• Enrollment (Actual): 32
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Valencia, Spain, 46001
    • Universidad Católica de Valencia San Vicente Mártir

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 39 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

Description

Inclusion Criteria:

• Male players
• Semi-professional players who are currently active
• Not have suffered a lower limb injury in the last 6 months before the study
• Not having suffered a rupture of the triceps surae
• Contain a latent trigger point in the medial gastrocnemius

Exclusion Criteria:

• Players suffering from any disease that could alter the study or be contradictory

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Placebo Comparator: Control; The simulated mode technique is applied (machine off)	Other: Placebo; simulated TECAR Therapy (machine off)
Experimental: TECAR THERAPY; The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.	Procedure: TECAR Therapy; The intervention will be performed with the T-Care TECAR® therapy machine at the latent trigger points of both gastrocnemius. The professional will apply the therapy with the generator that emits radio frequency signals of 0.5 MHz at a variable power with a maximum of 300W. The frequency to be used will be 500MHz with an intensity of 40% and with direct current.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain intensity	Visual analogue scale (VAS) of pain	30 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Back flexion	LUNGE Test	30 minutes
Thermographic evaluation	Ymiko Wifi Digital Weather Station with FLIR E60 camera and interpreted with FLIR tools software.	30 minutes

Collaborators and Investigators

• Sponsor: Fundación Universidad Católica de Valencia San Vicente Mártir
• Investigators: Study Director: Carlos Barrios, PhD, Universidad Católica de Valencia San Vicente Mártir

Study record dates

Study Major Dates

• Study Start (Actual): June 1, 2018
• Primary Completion (Actual): August 28, 2020
• Study Completion (Actual): August 28, 2020

Study Registration Dates

• First Submitted: March 23, 2020
• First Submitted That Met QC Criteria: March 25, 2020
• First Posted (Actual): March 30, 2020

Study Record Updates

• Last Update Posted (Actual): September 29, 2020
• Last Update Submitted That Met QC Criteria: September 28, 2020
• Last Verified: September 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Wounds and Injuries; Body Temperature Changes; Heat Stress Disorders; Hyperthermia
• Other Study ID Numbers: UCV2017-2018-40

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No